Unique Characteristics and Outcomes of Patients Diagnosed With Both Primary Thyroid and Primary Renal Cell Carcinoma

Brown, 2008, The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer, J Clin Endocrinol Metab, 93, 504, 10.1210/jc.2007-1154 Canchola, 2006, Risk of second primary malignancies in women with papillary thyroid cancer, Am J Epidemiol, 163, 521, 10.1093/aje/kwj072 Rubino, 2003, Second primary malignancies in thyroid cancer patients, Br J Cancer, 89, 1638, 10.1038/sj.bjc.6601319 Ronckers, 2005, Thyroid cancer and multiple primary tumors in the SEER cancer registries, Int J Cancer, 117, 281, 10.1002/ijc.21064 Sandeep, 2006, Second primary cancers in thyroid cancer patients: a multinational record linkage study, J Clin Endocrinol Metab, 91, 1819, 10.1210/jc.2005-2009 Berthe, 2004, Risk of second primary cancer following differentiated thyroid cancer, Eur J Nucl Med Mol Imaging, 31, 685, 10.1007/s00259-003-1448-y Lal, 2012, Risk of subsequent primary thyroid cancer after another malignancy: latency trends in a population-based study, Ann Surg Oncol, 19, 1887, 10.1245/s10434-011-2193-2 Chakraborty, 2013, Incidence and prognostic significance of second primary cancers in renal cell carcinoma, Am J Clin Oncol, 36, 132, 10.1097/COC.0b013e3182438ddf Rabbani, 1998, Multiple primary malignancies in renal cell carcinoma, J Urol, 160, 1255, 10.1016/S0022-5347(01)62510-2 Siegel, 2014, Cancer statistics, 2014, CA Cancer J Clin, 64, 9, 10.3322/caac.21208 National Cancer Institute. Available at: www.cancer.gov. Looyenga, 2011, Chromosomal amplification of leucine-rich repeat kinase-2 (LRRK2) is required for oncogenic MET signaling in papillary renal and thyroid carcinomas, Proc Natl Acad Sci U S A, 108, 1439, 10.1073/pnas.1012500108 Malchoff, 2000, Papillary thyroid carcinoma associated with papillary renal neoplasia: genetic linkage analysis of a distinct heritable tumor syndrome, J Clin Endocrinol Metab, 85, 1758 Catalogue of Somatic Mutations In Cancer. Available at: http://cancer.sanger.ac.uk/cancergenome/projects/cosmic/. Sherman, 2011, A phase II trial of the multitargeted kinase inhibitor E7080 in advanced radioiodine (RAI)-refractory differentiated thyroid cancer (DTC) [abstract], J Clin Oncol, 29 Rabbani, 2000, Second primary malignancies associated with renal cell carcinoma: influence of histologic type, Urology, 56, 399, 10.1016/S0090-4295(00)00682-8 National Cancer Institute: Surveillance, Epidemiology and End Results Program. Available at: http://seer.cancer.gov/about/overview.html. Sawka, 2009, Second primary malignancy risk after radioactive iodine treatment for thyroid cancer: a systematic review and meta-analysis, Thyroid, 19, 451, 10.1089/thy.2008.0392 Verkooijen, 2006, The incidence of second primary tumors in thyroid cancer patients is increased, but not related to treatment of thyroid cancer, Eur J Endocrinol, 155, 801, 10.1530/eje.1.02300 Sadetzki, 2003, Second primary breast and thyroid cancers (Israel), Cancer Causes Control, 14, 367, 10.1023/A:1023908509928 Vassilopoulou-Sellin, 1999, Incidence of breast carcinoma in women with thyroid carcinoma, Cancer, 85, 696, 10.1002/(SICI)1097-0142(19990201)85:3<696::AID-CNCR20>3.0.CO;2-4 Van Fossen, 2013, Association of thyroid, breast and renal cell cancer: a population- based study of the prevalence of second malignancies, Ann Surg Oncol, 20, 1341, 10.1245/s10434-012-2718-3 Boice, 1985, Introduction to the study of multiple primary cancers, Natl Cancer Inst Monogr, 68, 3 Schottenfeld, 1996, Cancer Epidemiology and Prevention Begg, 1995, Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program, Am J Epidemiol, 142, 653, 10.1093/oxfordjournals.aje.a117689 Wynder, 1977, Tobacco and alcohol consumption in relation to the development of multiple primary cancers, Cancer, 40, 1872, 10.1002/1097-0142(197710)40:4+<1872::AID-CNCR2820400817>3.0.CO;2-# Linehan, 2005, The genetic basis of cancer of kidney cancer: implications for gene-specific clinical management, BJU Int, 95, 2, 10.1111/j.1464-410X.2005.05189.x Loh, 1997, Familial nonmedullary thyroid carcinoma: a meta-review of case series, Thyroid, 7, 107, 10.1089/thy.1997.7.107 Subramanian, 2007, Second primary malignancy risk in thyroid cancer survivors: a systematic review and meta-analysis, Thyroid, 17, 1277, 10.1089/thy.2007.0171